Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Phase II Randomized Non-comparative Study of SC Tocilizumab Associated With IV Pulse Steroid Versus IV Pulse Steroid Alone for the Treatment of Acute Anterior Ischemic Optic Neuropathy Associated With Giant Cell Arteritis

NCT04239196 is registered in ClinicalTrials.gov with Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts as lead sponsor.

NCT NCT04239196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04239196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Phase II Randomized Non-comparative Study of SC Tocilizumab Associated With IV Pulse Steroid Versus IV Pulse Steroid Alone for the Treatment of Acute Anterior Ischemic Optic Neuropathy Associated With Giant Cell Arteritis
Lead sponsor
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Phase
Phase 2
Overall status
Unknown status
Start date
September 10, 2020
Completion date
December 10, 2022
Enrollment
58 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

giant cell arteritis, optic ischaemic neuropathy